Smead Capital Management, Inc. Amgen Inc Transaction History

Smead Capital Management, Inc.

$6.82 Billion
Q3 2024

A detailed history of Smead Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Smead Capital Management, Inc. holds 1,172,866 shares of AMGN stock, worth $309 Million. This represents 5.54% of its overall portfolio holdings.

Number of Shares

1,172,866

Previous 1,133,307 3.49%

Holding current value

$309 Million

Previous $354 Million 6.72%

% of portfolio

5.54%

Previous 5.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $12.2 Million - $13.3 Million	39,559 Added 3.49%	1,172,866 $378 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $15.6 Million - $19 Million	59,456 Added 5.54%	1,133,307 $354 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $11.9 Million - $14.3 Million	44,083 Added 4.28%	1,073,851 $305 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $20.6 Million - $23.2 Million	-80,556 Reduced 7.26%	1,029,768 $297 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $8.36 Million - $10.4 Million	-38,229 Reduced 3.33%	1,110,324 $298 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $2.87 Million - $3.39 Million	-13,398 Reduced 1.15%	1,148,553 $255 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $4.46 Million - $5.43 Million	19,747 Added 1.73%	1,161,951 $281 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $22.4 Million - $28.5 Million	97,915 Added 9.38%	1,142,204 $300 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $3.72 Million - $4.2 Million	16,586 Added 1.61%	1,044,289 $235 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $14.2 Million - $15.8 Million	61,712 Added 6.39%	1,027,703 $250 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $32.9 Million - $36.4 Million	150,001 Added 18.38%	965,991 $234 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $41.9 Million - $48 Million	210,890 Added 34.85%	815,990 $184 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $16.9 Million - $19.8 Million	79,468 Added 15.12%	605,100 $129 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $14.3 Million - $15.8 Million	61,010 Added 13.13%	525,632 $128 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $15.8 Million - $18.4 Million	71,336 Added 18.14%	464,622 $116 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $3.25 Million - $3.87 Million	-15,020 Reduced 3.68%	393,286 $90.4 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $10.4 Million - $11.5 Million	-44,186 Reduced 9.77%	408,306 $104 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $15.5 Million - $19 Million	-78,139 Reduced 14.73%	452,492 $107 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $18.9 Million - $25 Million	-103,508 Reduced 16.32%	530,631 $108 Million
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $1.09 Million - $1.4 Million	5,753 Added 0.92%	634,139 $153 Million
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $3.08 Million - $3.7 Million	-17,713 Reduced 2.74%	628,386 $122 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $3.45 Million - $4.04 Million	-20,666 Reduced 3.1%	646,099 $119 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $2.75 Million - $3.1 Million	-15,210 Reduced 2.23%	666,765 $127 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $5.3 Million - $6.18 Million	-29,682 Reduced 4.17%	681,975 $133 Million
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $3.3 Million - $3.72 Million	-17,812 Reduced 2.44%	711,657 $148 Million
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $2.17 Million - $2.44 Million	-13,089 Reduced 1.76%	729,469 $135 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $10.2 Million - $12 Million	60,444 Added 8.86%	742,558 $127 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $5.2 Million - $5.81 Million	-30,788 Reduced 4.32%	682,114 $119 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $119 Million - $136 Million	712,902	712,902 $133 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Smead Capital Management, Inc. with notifications on news.

Account

Smead Capital Management, Inc. Amgen Inc Transaction History